All cases were molecularly classified into the four main medulloblastomas subgroups, namely, WNT activated (n=40, 15%), SHH activated (n=122, 46%), Group 3 (n=42, 16%), and Group 4 (n=62, 23%) (Figure 1A). Here, SHH is linked to medulloblastoma.